Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.
Guggenheim Downgrades Albireo Pharma to Neutral
Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.
Related Posts
Biden Cracks Joke About Boeing-Made Air Force One: ‘I Don’t Sit By The Door’
President Joe Biden laughed about Boeing aircraft on Thursday at a campaign reception in New York.
MoffettNathanson Initiates Coverage On CrowdStrike Holdings with Buy Rating, Announces Price Target of $280
MoffettNathanson analyst Jackson Ader initiates coverage on CrowdStrike Holdings (NASDAQ:CRWD) with a Buy rating and announces Price Target of $280.
Google Battles Two Separate Class Actions In UK, Dutch Courts With Claims Of €25B
A law firm on behalf of publishers slapped damages claims for up to €25 billion ($25.4 billion) on Alphabet…